At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
General Activities
* Provide regulatory compliance oversight across the end-to-end product lifecycle (GPS and R&D) for software development and validation lifecycle activities associated with regulated computerized systems to ensure conformance to cGxPs, guidance documents, applicable industry accepted standards and BMS requirements.
* Carries out functions of the GQ GxP-ITQA Quality and eCompliance tower as directed including but not limited to:
* Review and approval of key computer system validation life cycle (VLC) deliverables
* Oversight of key software development life cycle (SDLC) process such as problem, incident, change, release, etc.
* Ensure adequate and timely regulatory compliance support
* Report on key metrics across the tower
* Provide active support during regulatory agency and third party inspections
* Research new technologies, understand existing processes, and reference recognized standards and frameworks
* Operate effectively and with minimal supervision, within a team or independently, performing special projects and related duties, as assigned
* Pursue continuous professional development through company paid internal/external training, certifications and/or continuing education.
* Identify opportunities for continuous improvement
* Adherence to BMS core behaviors
Degree Requirements
University graduate (science degree preferred) University Graduate; Life-Sciences degree preferred.
Experience Requirements
Proven experience in the interpretation and understanding of GxPs for the controlled management of electronic records and signatures (minimum 5-7 years experience).
Key Competency Requirements
* Experience with Trackwise or similar quality management systems preferred
* Experience in the Biotech/Pharmaceutical Industry or similar, regulated industry required
* Excellent analytical, interpersonal and communication skills, including written and verbal communication
* Previous experience as a quality manager for a life sciences company regulated by the FDA preferred
* In-depth understanding of industry accepted software development and validation life cycle programs and related IT controls
* Previous experience in risk-based approach to computerized system validation a plus. Understanding of quality risk-management concepts (ICH Q9) preferred
* Good understanding of the drug and device development process from discovery through to regulatory filing and approval of drug applications as well as commercial manufacturing processes
* Strong sense of ethics, diplomacy and discretion
* Commitment to Quality
* Strong critical thinking to analyze complex situations and discern critical issues
* Ability to manage various projects, create and work within internal timeliness, solve problems, deliver on commitments and utilize interpersonal skills in a cross-functional team
* Able to work effectively with multicultural workforce
* Excellent team player attitude
* Ability to manage competing priorities
Travel Required (nature and frequency):
About 5-10 % travel to meet with stakeholders, attend professional meetings and seminars
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or any part of the recruitment process direct your inquiries to adastaffingsupport@bms.com. Visit careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.
New York, New York
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.
It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.
The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.